Skip to main content

Institute of Medical Biology, Chinese Academy of Medical Sciences

The Institute of Medical Biology, Chinese Academy of Medical Sciences (IMBCAMS) was founded in 1958, and it integrates basic medical research with the development and production of biological products. It is mainly involved in basic and applied research in the following fields: medical virology, immunology, molecular biological technology, medical genetics, molecular epidemiology, experimental zoology and animal experimental technology using primates and large-scale production of vaccines as well as immunological and genetic engineering products.

IMBCAMS is the oldest and largest research and production base for a series of poliomyelitis and hepatitis A vaccines, which has made great contributions to the control and eradication of poliomyelitis and played an essential role in controlling the prevalence, reducing the number of outbreaks and decreasing the incidence of hepatitis A in China.

Prior to the solid theoretical base, rich research accumulation and professional talent teams gradually developed in the past over 50 years, as “WHO Collaborative and Research Center on Enteroviruses”, “International S&T Cooperation Base of Development and Industrialization for Infectious Disease Vaccines of China”, “National Torch Plan Key High-Tech Enterprise”, “National Engineering Research Center of Biological Product on Virus Diseases”, IMBCAMS has accumulated an solid and extensive basis for applied basic research and development of new products, and has established an independent innovation system for vaccine research and development. According to the requirements of national infectious disease prevention and control system, the new vaccine of Inactivated Poliomyelitis Vaccine made from attenuated Sabin strains is licensed in January 2015, and Inactivated Enterovirus 71 Vaccine (human diploid cell) is to be licensed by 2015.